Treating the endometrial stromal cells of endometriosis patients with antagonists of Tcf/β-catenin complexes significantly decreased the expression of fibrotic markers such as α-smooth muscle actin, type I collagen (Col-1), connective tissue growth factor (CTGF), and fibronectin. The gene discussed is HNF4A; the disease is endometriosis.